RPRX: Royalty Pharma plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 15,592.80
Enterprise Value ($M) 24,895.59
Book Value ($M) 9,525.37
Book Value / Share 21.49
Price / Book 1.64
NCAV ($M) -4,733.19
NCAV / Share -10.68
Price / NCAV -3.29

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) 0.00

Liquidity (mrq)
Quick Ratio 2.19
Current Ratio 2.19

Balance Sheet (mrq) ($M)
Current Assets 2,554.91
Assets 16,813.47
Liabilities 7,288.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,237.00
Operating Income 923.00
Net Income 43.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,144.00
Cash from Investing -1,029.00
Cash from Financing -945.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A General Atlantic Llc 5.60 0.00
02-10 13G/A Morgan Stanley 9.90 -21.85
02-09 13G/A Adage Capital Partners Gp, L.l.c. 1.59 -71.82
02-09 13G/A Fmr Llc 10.00 99.78
02-09 13G/A Vanguard Group Inc 8.08 20.22
10-04 13D/A Giuliani Mario Germano 10.00 -5.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2022-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-03-21 204,246 1,378,976 14.81
2023-03-20 297,065 1,912,847 15.53
2023-03-17 428,396 2,389,440 17.93
2023-03-16 254,779 2,233,628 11.41

(click for more detail)

Similar Companies
RNXT – RenovoRx, Inc. ROIV – Roivant Sciences Ltd
RPHM – Reneo Pharmaceuticals, Inc. RPTX – Repare Therapeutics Inc
RTVA – Artiva Biotherapeutics Inc


Financial data and stock pages provided by
Fintel.io